🇺🇸 FDA
Patent

US 7547773

Nucleic acid molecules encoding prostate specific antigen oligo epitope peptides

granted A61KA61K2035/124A61K2039/5154

Quick answer

US patent 7547773 (Nucleic acid molecules encoding prostate specific antigen oligo epitope peptides) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
35
CPC classes
A61K, A61K2035/124, A61K2039/5154, A61K2039/5156, A61K2039/5158